Navigation Links
Stealthy killer in Australia: Ovarian Cancer

Ovarian cancer continues to be a stealthy killer in Australia since almost of the cases that are diagnosed //are sadly in the advanced stages. Reports reveal that less than half of the women diagnosed with ovarian cancer survive the illness beyond five years. Only about 42% of patients survive when compared to the 87% of patients with breast cancer, revealed a Federal government report. The survival rate is low for ovarian cancer cases as this form of cancer has fewer symptoms and has no suitable screening tests that can lead to an early diagnosis.

The most recent reports released by the Australian Institute of Health and Welfare and the National Breast Cancer Center in Australia, show that survival rates of women with ovarian cancer has improved visibly by almost 8% in the last decade.

Dr Helen Zorbas, the director of National Breast Cancer Center said that it would take a few more years before a suitable screening test for ovarian cancer is made available to the public. Owing to the vague symptoms that this cancer presents with, it is often overlooked and an early diagnosis is often missed. She has exhorted women to take note of any unusual symptoms related to their bowel habits or urinary habits and to report to their GP in such instances immediately.

Generally it has been noted that ovarian cancer affects women over the age of 60.The out come of the disease seems to be more favorable for younger patients. The incidence of the cancer in Australia is significantly lesser than other countries like New Zealand, UK, US and Canada.


MST
'"/>




Page: 1

Related medicine news :

1. Painkillers Do Not Shorten Dying Patients Lives
2. Water - The silent killer!!!
3. Virus killer
4. Strong pain killers likely to cause miscarriage
5. Sleeping sickness - a silent killer
6. Chlamydia toxin- a secret killer
7. Drug dilemma confronts users of painkillers
8. Painkiller Linked to Deaths
9. Canine Painkiller unveiled by Novartis
10. Painkillers may protect against Alzheimers disease
11. Painkillers may raise miscarriage risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... Advice Media, the industry leader in digital ... companies in North America and has been included in the Inc. 5000 for the second ... honored to be included in the Inc. 5000 rankings for the second year in a ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... ... August 16, 2017 , ... The next Patient Care ... accepted. , Students who successfully complete the seven-week long Patient Care Academy are ... (CNA). The average starting salary for a CNA in Kalamazoo is $24,428.* , As ...
(Date:8/16/2017)... ... August 16, 2017 , ... Greenfield Advisors is honored to be named to ... second year in a row. The Inc. 5000 list honors private businesses across the ... on the list once is a great accomplishment, but for us to be included ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Any Lab ... 5000. The company ranked #4429 on the newly released, 36th annual Inc. 5000 ... a unique look at the most successful companies within the American economy’s most dynamic ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology: